
Michael Thanh Tran
Examiner (ID: 128, Phone: (571)272-1795 , Office: P/2827 )
| Most Active Art Unit | 2827 |
| Art Unit(s) | 2818, 2511, 2827 |
| Total Applications | 3169 |
| Issued Applications | 2956 |
| Pending Applications | 141 |
| Abandoned Applications | 104 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16970492
[patent_doc_number] => 11066453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/573920
[patent_app_country] => US
[patent_app_date] => 2016-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 29
[patent_no_of_words] => 22194
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15573920
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/573920 | Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof | May 16, 2016 | Issued |
Array
(
[id] => 16999719
[patent_doc_number] => 11078515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Methods for identifying targets for antimicrobial and antiproliferative compounds and compositions therefrom
[patent_app_type] => utility
[patent_app_number] => 15/572899
[patent_app_country] => US
[patent_app_date] => 2016-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 11828
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15572899
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/572899 | Methods for identifying targets for antimicrobial and antiproliferative compounds and compositions therefrom | May 10, 2016 | Issued |
Array
(
[id] => 11129247
[patent_doc_number] => 20160326222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'CLOSTRIDIUM DIFFICILE VACCINE'
[patent_app_type] => utility
[patent_app_number] => 15/148503
[patent_app_country] => US
[patent_app_date] => 2016-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 18516
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15148503
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/148503 | CLOSTRIDIUM DIFFICILE VACCINE | May 5, 2016 | Abandoned |
Array
(
[id] => 12766201
[patent_doc_number] => 20180147235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => ALLERGY VACCINE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 15/570851
[patent_app_country] => US
[patent_app_date] => 2016-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570851
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/570851 | Allergy vaccine composition | Apr 27, 2016 | Issued |
Array
(
[id] => 15915345
[patent_doc_number] => 10654901
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Microorganisms with increased photosynthetic capacity
[patent_app_type] => utility
[patent_app_number] => 15/569022
[patent_app_country] => US
[patent_app_date] => 2016-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14084
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569022
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569022 | Microorganisms with increased photosynthetic capacity | Apr 21, 2016 | Issued |
Array
(
[id] => 15541269
[patent_doc_number] => 10570401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Compositions and method for destabilizing, altering, and dispersing biofilms
[patent_app_type] => utility
[patent_app_number] => 15/134007
[patent_app_country] => US
[patent_app_date] => 2016-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10742
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15134007
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/134007 | Compositions and method for destabilizing, altering, and dispersing biofilms | Apr 19, 2016 | Issued |
Array
(
[id] => 11046232
[patent_doc_number] => 20160243191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'Compositions for the Treatment of Cancer, and Methods for Testing and Using the Same'
[patent_app_type] => utility
[patent_app_number] => 15/082626
[patent_app_country] => US
[patent_app_date] => 2016-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10818
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15082626
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/082626 | Compositions for the treatment of cancer, and methods for testing and using the same | Mar 27, 2016 | Issued |
Array
(
[id] => 15571557
[patent_doc_number] => 10576137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Oligosialic acid derivatives, methods of manufacture, and immunological uses
[patent_app_type] => utility
[patent_app_number] => 15/082905
[patent_app_country] => US
[patent_app_date] => 2016-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 23
[patent_no_of_words] => 41505
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15082905
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/082905 | Oligosialic acid derivatives, methods of manufacture, and immunological uses | Mar 27, 2016 | Issued |
Array
(
[id] => 11046232
[patent_doc_number] => 20160243191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'Compositions for the Treatment of Cancer, and Methods for Testing and Using the Same'
[patent_app_type] => utility
[patent_app_number] => 15/082626
[patent_app_country] => US
[patent_app_date] => 2016-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10818
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15082626
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/082626 | Compositions for the treatment of cancer, and methods for testing and using the same | Mar 27, 2016 | Issued |
Array
(
[id] => 11289145
[patent_doc_number] => 20160339077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'TREATMENT AND DIAGNOSIS OF INFLAMMATORY DISORDERS AND HIV'
[patent_app_type] => utility
[patent_app_number] => 15/080089
[patent_app_country] => US
[patent_app_date] => 2016-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16767
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15080089
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/080089 | Treatment and diagnosis of inflammatory disorders and HIV | Mar 23, 2016 | Issued |
Array
(
[id] => 12184066
[patent_doc_number] => 20180043002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'GLYCOCONJUGATE VACCINE FOR LEISHMANIASIS'
[patent_app_type] => utility
[patent_app_number] => 15/555369
[patent_app_country] => US
[patent_app_date] => 2016-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4930
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555369
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/555369 | Glycoconjugate vaccine for | Mar 21, 2016 | Issued |
Array
(
[id] => 13383701
[patent_doc_number] => 20180243392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => CS21 AND LNGA PROTEIN VACCINES
[patent_app_type] => utility
[patent_app_number] => 15/558761
[patent_app_country] => US
[patent_app_date] => 2016-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558761
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/558761 | CS21 AND LNGA PROTEIN VACCINES | Mar 16, 2016 | Abandoned |
Array
(
[id] => 12159189
[patent_doc_number] => 20180030456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'ENHANCED PROTEIN EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 15/550623
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13914
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550623
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550623 | ENHANCED PROTEIN EXPRESSION | Feb 18, 2016 | Abandoned |
Array
(
[id] => 10820543
[patent_doc_number] => 20160166707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'Stabilization of Therapeutic Agents to Facilitate Administration'
[patent_app_type] => utility
[patent_app_number] => 15/048393
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7265
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15048393
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/048393 | Stabilization of therapeutic agents to facilitate administration | Feb 18, 2016 | Issued |
Array
(
[id] => 16563264
[patent_doc_number] => 10888611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 15/543232
[patent_app_country] => US
[patent_app_date] => 2016-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 44200
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15543232
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/543232 | None | Feb 15, 2016 | Issued |
Array
(
[id] => 12157360
[patent_doc_number] => 20180028626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/550567
[patent_app_country] => US
[patent_app_date] => 2016-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26345
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550567
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550567 | IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY | Feb 11, 2016 | Abandoned |
Array
(
[id] => 11758538
[patent_doc_number] => 20170205407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'PROTEINS USED FOR THE DIAGNOSIS OF LYME BORRELIOSIS'
[patent_app_type] => utility
[patent_app_number] => 15/019520
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8228
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019520
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019520 | Proteins used for the diagnosis of lyme borreliosis | Feb 8, 2016 | Issued |
Array
(
[id] => 11031572
[patent_doc_number] => 20160228529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'MENINGOCOCCAL VACCINE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/011216
[patent_app_country] => US
[patent_app_date] => 2016-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13576
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15011216
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/011216 | MENINGOCOCCAL VACCINE FORMULATIONS | Jan 28, 2016 | Abandoned |
Array
(
[id] => 12117324
[patent_doc_number] => 20180000911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'Mosquito Saliva Protein Malaria Vaccine'
[patent_app_type] => utility
[patent_app_number] => 15/546747
[patent_app_country] => US
[patent_app_date] => 2016-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13607
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15546747
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/546747 | Mosquito saliva protein malaria vaccine | Jan 25, 2016 | Issued |
Array
(
[id] => 11002473
[patent_doc_number] => 20160199422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER USING BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 15/003726
[patent_app_country] => US
[patent_app_date] => 2016-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13702
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15003726
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/003726 | Compositions and methods for treatment of cancer using bacteria | Jan 20, 2016 | Issued |